Blog
RSS FeedPosted by Michael Wonder on 14 Sep 2021
Trodelvy approved by the TGA
14 September 2021 - Sacituzumab govitecan is a new treatment option for adult patients with unresectable locally advanced or metastatic triple negative ...
Posted by Michael Wonder on 14 Sep 2021
New therapy to treat advanced small cell lung cancer approved for Australian patients
14 September 2021 - Zepzelca approval granted under a provisional regulatory pathway. ...
Posted by Michael Wonder on 14 Sep 2021
Access Consortium: alignment with ICMRA consensus on immunobridging for authorising new COVID-19 vaccines
14 September 2021 - Placebo controlled disease outcome trial data are the gold standard for authorising vaccines. However, for COVID-19 ...
Posted by Michael Wonder on 13 Sep 2021
Joint statement of support for an Australian Patent Box
13 September 2021 - Australia’s health innovators support the introduction of a Patent Box, and we welcome this initiative by the ...
Posted by Michael Wonder on 13 Sep 2021
Trodelvy approved following heroic efforts of breast cancer sufferer Alison Day
12 September 2021 - A dying woman’s selfless campaign will give Australian women battling a rare aggressive form of breast cancer ...
Posted by Michael Wonder on 09 Sep 2021
COVID-19 vaccine weekly safety report (9 September 2021)
9 September 2021 - To 5 September 2021, approximately 21 million vaccine doses have been given in Australia – 13.1 million ...
Posted by Michael Wonder on 07 Sep 2021
TGA approves new cancer medicine
7 September 2021 - Luspatercept (Reblozyl) is used to treat patients with certain transfusion-dependent anaemias. ...
Posted by Michael Wonder on 06 Sep 2021
Statement on Moderna COVID-19 vaccine
6 September 2021 - Medicines Australia welcomes the TGA provisional approval for the COVID-19 vaccine, Spikevax (Moderna) for Australia. The ...
Posted by Michael Wonder on 04 Sep 2021
COVID-19 vaccine: Spikevax (elasomeran)
4 September 2021 - On 3 September 2021, the TGA granted provisional approval to Moderna Australia for the use of ...
Posted by Michael Wonder on 02 Sep 2021
COVID-19 vaccine weekly safety report (2 September 2021)
2 September 2021 - To 29 August 2021, over 19 million vaccine doses have been given in Australia – approximately 12 ...
Posted by Michael Wonder on 29 Aug 2021
COVID-19 vaccine claims scheme
29 August 2021 - Medicines Australia commends the Australian Government on the COVID-19 Vaccine Claim Scheme for anyone who experiences ...
Posted by Michael Wonder on 28 Aug 2021
No fault COVID-19 indemnity scheme
28 August 2021 - The Morrison Government has finalised the details of the no fault COVID-19 Vaccine Claim Scheme following extensive ...
Posted by Michael Wonder on 28 Aug 2021
ATAGI recommendations on the use of COVID-19 vaccines in all young adolescents in Australia
27 August 2021 - Vaccination against COVID-19 is recommended for all individuals from 12 years of age, extending the current ...
Posted by Michael Wonder on 26 Aug 2021
COVID-19 vaccine weekly safety report (26 August 2021)
26 August 2021 - To 22 August 2021, approximately 17.1 million vaccine doses have been given in Australia – 10.9 million ...
Posted by Michael Wonder on 23 Aug 2021
TGA grants provisional determination to Celltrion Healthcare's anti-viral COVID-19 treatment regdanvimab
23 August 2021 - On 20 August 2021 the TGA granted provisional determination to Celltrion Healthcare in relation to regdanvimab. ...